Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma.
2021
Keywords:
-
Correction
-
Source
-
Cite
-
Save
9
References
0
Citations
NaN
KQI